Following a 1-for-4 reverse stock split, Nasdaq initially deemed Profusa non-compliant with the $500,000 publicly held shares minimum requirement. However, a subsequent amendment confirmed the company regained compliance as of August 21, 2026. Market focus may revert to its underlying digital health sensor business and future trading stability.